Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    10349689 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Ribavirin Dose Optimization for the Treatment of Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Drug: Peg-interferon alpha-2a, Ribavirin

Study has passed its completion date and status has not been verified in more than two years.